Vycor Medical, Inc. (VYCO)
OTCMKTS · Delayed Price · Currency is USD
0.0440
0.00 (0.00%)
At close: Nov 9, 2026
Vycor Medical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1 | 4 | 2 | 3 | 3 | 3 | |
Market Cap Growth | -74.86% | 73.10% | -7.39% | -13.98% | -2.83% | 12.15% |
Enterprise Value | 2 | 5 | 3 | 4 | 4 | 4 |
Last Close Price | 0.04 | 0.12 | 0.07 | 0.08 | 0.09 | 0.10 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.81 | 2.17 | 1.47 | 1.73 | 2.39 | 2.16 |
PB Ratio | - | -0.99 | -0.63 | -0.76 | -1.00 | -1.26 |
P/FCF Ratio | 24.56 | - | 42.61 | 125.67 | - | - |
P/OCF Ratio | 23.92 | - | 38.81 | 85.59 | - | 141.02 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.25 | 2.69 | 2.05 | 2.45 | 3.15 | 2.75 |
EV/EBITDA Ratio | 11.69 | 51.62 | 59.49 | 35.49 | - | - |
EV/EBIT Ratio | 47.02 | 147.78 | - | 89.14 | - | - |
EV/FCF Ratio | 37.93 | - | 59.51 | 178.73 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -0.22 | -0.25 | -0.29 | -0.33 | -0.34 | -0.36 |
Debt / EBITDA Ratio | 4.94 | 5.63 | 7.65 | 6.33 | - | - |
Debt / FCF Ratio | 16.02 | - | 19.32 | 55.39 | - | - |
Net Debt / Equity Ratio | -0.19 | -0.22 | -0.26 | -0.32 | -0.32 | -0.32 |
Net Debt / EBITDA Ratio | 7.24 | 9.49 | 17.38 | 10.43 | -3.90 | -2.11 |
Net Debt / FCF Ratio | 13.36 | -49.29 | 17.39 | 52.53 | -4.35 | -45.67 |
Asset Turnover | 2.14 | 2.04 | 1.60 | 1.58 | 1.36 | 1.45 |
Inventory Turnover | 1.74 | 1.98 | 0.88 | 0.60 | 0.62 | 0.69 |
Quick Ratio | 0.07 | 0.06 | 0.08 | 0.07 | 0.05 | 0.07 |
Current Ratio | 0.13 | 0.12 | 0.14 | 0.14 | 0.14 | 0.16 |
Return on Assets (ROA) | 3.56% | 2.32% | -0.57% | 2.71% | -21.34% | -28.35% |
Return on Capital Employed (ROCE) | -1.20% | -0.90% | 0.30% | -1.30% | 11.00% | 19.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -26.17% | -1.79% | -4.59% | -2.77% | -13.83% | -14.46% |
FCF Yield | 4.07% | -0.46% | 2.35% | 0.80% | -7.51% | -0.56% |
Buyback Yield / Dilution | -0.35% | -1.48% | -0.86% | -2.83% | -7.02% | -13.51% |